Savara, Inc. (SVRA)
5.565
-0.02
(-0.45%)
USD |
NASDAQ |
Aug 24, 16:00
5.565
0.00 (0.00%)
After-Hours: 20:00
Savara Shareholders Equity (Quarterly) : 143.66M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 143.66M |
| March 31, 2026 | 176.04M |
| December 31, 2025 | 203.13M |
| September 30, 2025 | 94.39M |
| June 30, 2025 | 120.48M |
| March 31, 2025 | 147.85M |
| December 31, 2024 | 171.45M |
| September 30, 2024 | 199.35M |
| June 30, 2024 | 101.73M |
| March 31, 2024 | 121.86M |
| December 31, 2023 | 140.37M |
| September 30, 2023 | 146.54M |
| June 30, 2023 | 87.72M |
| March 31, 2023 | 98.26M |
| December 31, 2022 | 107.78M |
| September 30, 2022 | 116.51M |
| June 30, 2022 | 127.04M |
| March 31, 2022 | 136.48M |
| December 31, 2021 | 144.50M |
| September 30, 2021 | 155.23M |
| June 30, 2021 | 165.38M |
| March 31, 2021 | 175.12M |
| December 31, 2020 | 64.38M |
| September 30, 2020 | 76.63M |
| June 30, 2020 | 83.80M |
| Date | Value |
|---|---|
| March 31, 2020 | 87.32M |
| December 31, 2019 | 101.70M |
| September 30, 2019 | 106.80M |
| June 30, 2019 | 112.80M |
| March 31, 2019 | 101.80M |
| December 31, 2018 | 108.22M |
| September 30, 2018 | 117.85M |
| June 30, 2018 | 82.71M |
| March 31, 2018 | 93.70M |
| December 31, 2017 | 119.31M |
| September 30, 2017 | 74.64M |
| June 30, 2017 | 79.77M |
| March 31, 2017 | 4.35M |
| December 31, 2016 | 7.986M |
| September 30, 2016 | 13.19M |
| June 30, 2016 | 16.43M |
| March 31, 2016 | 20.68M |
| December 31, 2015 | 23.89M |
| September 30, 2015 | 33.54M |
| June 30, 2015 | 42.54M |
| March 31, 2015 | 50.11M |
| December 31, 2014 | 58.66M |
| September 30, 2014 | 45.25M |
| June 30, 2014 | 50.22M |
| March 31, 2014 | 52.79M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 11.83B |
| Insmed, Inc. | 757.49M |
| United Therapeutics Corp. | 6.400B |
| Vertex Pharmaceuticals, Inc. | 20.25B |
| SELLAS Life Sciences Group, Inc. | 137.66M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 192.14M |
| Total Liabilities (Quarterly) | 48.48M |
| Debt to Equity Ratio | 0.2117 |
| Current Ratio | 10.13 |
| Net Debt Paydown Yield | -0.01% |